Central China New Life Limited

HKEX:9983.HK

1.23 (HKD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 745.694745.694676.634676.634791.437791.437782.634782.6341,017.5461,017.546781.914781.914796.657796.657530.593530.593537.192537.192340.01340.01
Cost of Revenue 556.975556.975486.807486.807518.624518.624533.849533.849676.836676.836531.012531.012550.053550.053346.838346.838369.956369.956219.103219.103
Gross Profit 188.719188.719189.827189.827272.813272.813248.785248.785340.71340.71250.902250.902246.604246.604183.755183.755167.236167.236120.907120.907
Gross Profit Ratio 0.2530.2530.2810.2810.3450.3450.3180.3180.3350.3350.3210.3210.310.310.3460.3460.3110.3110.3560.356
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 58.12458.12440.79240.79267.18667.18652.23152.23141.94841.94872.88672.88680.64580.64556.03856.03870.46570.46544.69144.691
Selling & Marketing Expenses 4.3064.3064.6274.6277.3627.3628.6828.68215.63315.63312.91312.91315.18415.18411.27611.27615.90415.9047.3447.344
SG&A 318.925318.925349.327349.327105.503105.50388.83788.837108.33108.3385.79985.799103.458103.45867.31467.31486.36986.36952.03452.034
Other Expenses 002.96406.295000000000000000
Operating Expenses 356.774356.774372.035372.03596.1396.1363.18263.182106.014106.01481.77481.77494.65494.65464.29864.29884.0684.0650.13550.135
Operating Income -130.464-130.464-154.885-154.885172.767172.767169.867169.867245.485245.485169.44169.44148.863148.863119.538119.53882.46382.46369.54269.542
Operating Income Ratio -0.175-0.175-0.229-0.2290.2180.2180.2170.2170.2410.2410.2170.2170.1870.1870.2250.2250.1540.1540.2050.205
Total Other Income Expenses Net -36.733-36.733-26.007-26.0077.7747.77429.18329.183-4.649-4.6492.7512.7519.3749.3740.6810.6811.6011.6010.1650.165
Income Before Tax -167.196-167.196-180.892-180.892180.541180.541199.05199.05240.836240.836172.191172.191158.237158.237120.218120.21884.06484.06469.70769.707
Income Before Tax Ratio -0.224-0.224-0.267-0.2670.2280.2280.2540.2540.2370.2370.220.220.1990.1990.2270.2270.1560.1560.2050.205
Income Tax Expense 27.66927.66931.46631.46645.70645.70648.30248.30249.52849.52836.80636.80632.34732.34725.73625.73619.47619.47617.87617.876
Net Income -137.38-137.38-149.805-149.805136.223136.223144.908144.908179.696179.696130.084130.084121.387121.38791.90791.90763.01963.01956.48656.486
Net Income Ratio -0.184-0.184-0.221-0.2210.1720.1720.1850.1850.1770.1770.1660.1660.1520.1520.1730.1730.1170.1170.1660.166
EPS -0.11-0.11-0.12-0.120.110.110.110.110.140.140.10.10.0950.0950.090.090.0670.0670.0630.063
EPS Diluted -0.11-0.11-0.12-0.120.110.110.110.110.140.140.10.10.0940.0940.090.090.070.070.0630.063
EBITDA -121.814-121.814-145.142-145.142183.313183.313179.487179.487256.575256.575176.57176.57153.996153.996121.922121.92286.26686.26672.76572.765
EBITDA Ratio -0.163-0.163-0.215-0.2150.2320.2320.2290.2290.2520.2520.2260.2260.1930.1930.230.230.1610.1610.2140.214